Compare BSM & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BSM | HAE |
|---|---|---|
| Founded | 1876 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.8B |
| IPO Year | 2015 | 1996 |
| Metric | BSM | HAE |
|---|---|---|
| Price | $14.23 | $76.31 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 9 |
| Target Price | $14.00 | ★ $84.13 |
| AVG Volume (30 Days) | 284.6K | ★ 750.3K |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | ★ 8.40% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.05 |
| Revenue | $469,919,000.00 | ★ $910,373,000.00 |
| Revenue This Year | $11.03 | N/A |
| Revenue Next Year | $9.63 | $5.23 |
| P/E Ratio | ★ $12.82 | $37.32 |
| Revenue Growth | ★ 8.35 | N/A |
| 52 Week Low | $11.90 | $47.32 |
| 52 Week High | $15.49 | $87.32 |
| Indicator | BSM | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 56.02 | 58.24 |
| Support Level | $13.21 | $72.04 |
| Resistance Level | $14.25 | $80.90 |
| Average True Range (ATR) | 0.33 | 2.87 |
| MACD | 0.04 | -0.39 |
| Stochastic Oscillator | 61.65 | 55.68 |
Black Stone Minerals LP is an oil and natural gas mineral company. It owns oil and natural gas mineral interests, which makes up the majority of its asset base. Its business is actively managing an existing portfolio of mineral and royalty assets to maximize its value and expanding asset base through acquisitions of additional mineral and royalty interests. The company owns mineral interests in approximately 16.9 million gross acres.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.